Literature DB >> 15795516

Nutritional and inflammatory markers in the prediction of mortality in Chinese hemodialysis patients.

Chung-Ying Hung1, Yi-Ann Chen, Chia-Chi Chou, Chwei-Shiun Yang.   

Abstract

BACKGROUND/AIMS: The prevalence of cardiovascular disease and mortality rate is relatively low in Chinese dialysis patients. This study aimed to evaluate the predictive value of nutritional and inflammatory markers in Chinese hemodialysis patients.
METHODS: A total of 158 patients (70 men and 88 women, age 59.9 +/- 13.2 years) were studied. Nutritional and inflammatory markers, including subjective global assessment (SGA), insulin-like growth factor-1, albumin, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, serum amyloid A (SAA), and C-reactive protein (CRP), were measured. These patients were followed up until April 2004 (36 months) to determine the incidence and causes of death.
RESULTS: SGA (p = 0.001), IL-1beta (p = 0.032), SAA (p = 0.031), IL-6 (p = 0.001) and CRP (p < 0.001) were found to be significant predictors of mortality. After adjusting with age, sex, diabetes, coronary artery disease, Kt/Vurea, and duration on dialysis, CRP (odds ratio = 4.58; p = 0.038) and SGA (odds ratio = 6.57; p = 0.004) remained the independent predictors of mortality. The adjusted mortality rate was highest for patients with a high CRP level and malnutrition (assessed by SGA).
CONCLUSIONS: SGA and CRP levels are the most significant predictors of mortality in Chinese dialysis patients. Chinese dialysis patients with a high CRP level tend to be at higher risk of mortality only if they are malnourished.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15795516     DOI: 10.1159/000084654

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  7 in total

1.  Relationship between nutritional status and mortality during the first 2 weeks following treatment for cervical spinal cord injury.

Authors:  Xiaobin Chen; Zhi Liu; Tiansheng Sun; Jixin Ren; Xiaowei Wang
Journal:  J Spinal Cord Med       Date:  2013-10-24       Impact factor: 1.985

2.  Associations of interleukin-6, C-reactive protein and serum amyloid A with mortality in haemodialysis patients.

Authors:  James B Wetmore; David H Lovett; Adriana M Hung; Galen Cook-Wiens; Jonathan D Mahnken; Saunak Sen; Kirsten L Johansen
Journal:  Nephrology (Carlton)       Date:  2008-09-25       Impact factor: 2.506

3.  Endothelial dysfunction, inflammation and malnutrition markers as predictors of mortality in dialysis patients: multimarker approach.

Authors:  Aleksandra M Ignjatović; Tatjana P Cvetković; Radmila M Pavlović; Vidojko M Đorđević; Zoran G Milošević; Vidosava B Đorđević; Dušica D Pavlović; Ivana R Stojanović; Dragan Bogdanović
Journal:  Int Urol Nephrol       Date:  2013-04-17       Impact factor: 2.370

Review 4.  Obesity management in adults with CKD.

Authors:  Holly Kramer; Katherine R Tuttle; David Leehey; Amy Luke; Ramon Durazo-Arvizu; David Shoham; Richard Cooper; Srinvisan Beddhu
Journal:  Am J Kidney Dis       Date:  2009-01       Impact factor: 8.860

5.  Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat.

Authors:  M Teixeira; P Rodrigues-Santos; P Garrido; E Costa; B Parada; J Sereno; R Alves; L Belo; F Teixeira; A Santos-Silva; F Reis
Journal:  J Pharm Bioallied Sci       Date:  2012-01

6.  Association between nutritional, inflammatory and oxidative status (NIOS) and risk of adverse outcomes in patients on haemodialysis (HD): the NIOS-HD prospective cohort study protocol.

Authors:  Sahar Foshati; Gholamreza Askari; Mohammad Bagherniya; Mojgan Mortazavi; Firouzeh Moeinzadeh; Shahram Taheri; Zahra Heidari; Mohammad Hossein Rouhani
Journal:  BMJ Open       Date:  2022-09-20       Impact factor: 3.006

7.  A cohort study of insulin-like growth factor 1 and mortality in haemodialysis patients.

Authors:  Erik Nilsson; Juan Jesus Carrero; Olof Heimbürger; Olof Hellberg; Bengt Lindholm; Peter Stenvinkel
Journal:  Clin Kidney J       Date:  2015-11-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.